Foreign Media: Chinese scientists have made a breakthrough in blocking the progression of Parkinson's disease.
A research team from Huashan Hospital, Fudan University, China, discovered a new therapeutic target for Parkinson's disease, FAM171A2, and used artificial intelligence to screen out the anticancer drug phenylalanine as a potential treatment drug, which can effectively block the interaction between this gene and the pathological protein associated with Parkinson's disease.
This achievement was published in the journal "Science" and is considered to be promising for early intervention and slowing the progression of Parkinson's disease. Parkinson's disease is the second most common neurodegenerative disease after Alzheimer's disease, with about two-thirds of patients in China globally.
Current drugs and surgeries can only alleviate symptoms but cannot stop the progression of the disease. This study provides direction for developing small-molecule drugs, antibodies, and gene therapies for Parkinson's disease, and will promote clinical trials and innovative treatments in the future.
Original article: https://www.toutiao.com/article/1836505110547735/
Statement: This article represents the views of the author.